Hemorrhagic cystitis: A challenge to the urologist

R Manikandan, Santosh Kumar, Lalgudi N Dorairajan, R Manikandan, Santosh Kumar, Lalgudi N Dorairajan

Abstract

Severe hemorrhagic cystitis often arises from anticancer chemotherapy or radiotherapy for pelvic malignancies. Infectious etiologies are less common causes except in immunocompromised hosts. These cases can be challenging problems for the urologist and a source of substantial morbidity and sometimes mortality for the patients. A variety of modalities of treatment have been described for the management of hemorrhagic cystitis but there is none that is uniformly effective. Some progress has been made in the understanding and management of viral hemorrhagic cystitis. This article reviews the common causes of severe hemorrhagic cystitis and the currently available management options.

Keywords: Hemorrhagic cystitis; chemotherapy; immunosuppression; intravesical therapy; radiotherapy; viral cystitis.

Conflict of interest statement

Conflict of Interest: None declared

Figures

Figure 1
Figure 1
Management algorithm for hemorrhagic cystitis

References

    1. Talar-Williams C, Hijazi YM, Walther MM, Linehan WM, Lubensky I, Kerr GS, et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener’s granulomatosis. Ann Intern Med. 1996;124:477–84.
    1. Schoenike SE, Dana WJ. Ifosfamide and mesna. Clin Pharm. 1990;9:179–91.
    1. Ribeiro RA, Freitas HC, Campos MC, Santos CC, Figueriedo FC, Brito GA, et al. Tumor necrosis factor-alpha and interleukin-1 beta mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice. J Urol. 2002;167:2229–34.
    1. Kimura M, Tomita Y, Morishita H, Takahashi K. Presence of mucosal change in the urinary bladder in non hematuria patients with long-term exposure and/or accumulating high-dose cyclophosohamide. Possible significance of follow-up cystoscopy on preventing development of cyclophosphamide- induced hemorrhagic cystitis. Urol Int. 1998;61:8–11.
    1. Krane DM, Levine LA. Hemorrhagic cystitis. AUA Update Series. 1992;XI:Lesson 31.
    1. Cox PJ. Cyclophosphamide cystitis. Identification of acrolein as the causative agent. Biochem Pharmacol. 1979;28:2045–9.
    1. Stillwell TJ, Benson RC., Jr Cyclophosphamide- induced hemorrhagic cystitis. A review of 100 patients. Cancer. 1988;61:451–7.
    1. Fauci AS, Haynes BF, Katz P. Wegeners granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983;98:76–85.
    1. Shepard JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL. Mesna versus hyperhydration for the prevention of cyclophosphamide induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol. 1991;9:2016–20.
    1. Vose JM, Reed EC, Pippert GC, Anderson JR, Bierman PJ, Kessinger A, et al. Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: A randomized trial. J Clin Oncol. 1993;11:1306–10.
    1. Hadjibabaie M, Alimoghaddam K, Shamshiri AR, Iravani M, Bahar B, Mousavi A, et al. Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Urol Oncol. 2008;26:43–6.
    1. Hader JE, Marzella L, Myers RA, Jacob SC, Naslund MJ. Hyperbaric oxygen treatment for experimental cyclophosphamide- induced hemorrhagic cystitis. J Urol. 1993;149:1617–21.
    1. Batista CK, Mota JM, Souza ML, Leitao BT, Souza MH, Brito GA, et al. Amifostine: Glutathione prevent ifosfamide and acrolein-induced hemorrhagic cystitis. Cancer Chemother Pharmacol. 2007;59:71–7.
    1. Vieira MM, Brito GA, Belarmino-Filho JN, Macedo FY, Nery EA, Cunha FQ, et al. Use dexamethasone with mesna for the prevention of ifosfamide induced hemorrhagic cystitis. Int J Urol. 2003;10:595–602.
    1. Assreuy AM, Martins GJ, Moreira ME, Brito GAC, Cavada BS, Ribeiro RA, et al. Prevention of cyclophosphamide induced hemorrhagic cystitis by a glucose-mannose binding plant lectin. J Urol. 1999;10:1988–93.
    1. Fairchild WV, Spence CR, Solomon HD, Gangai MP. The incidence of bladder cancer after cyclophosphamide therapy. J Urol. 1979;122:163–4.
    1. Cannon J, Linke CA, Cos LR. Cyclophosphamide associated carcinoma of urothelium: Modalities for prevention. Urology. 1991;38:413–6.
    1. Islam R, Issacson BJ, Zickerman PM, Ratanawong C, Tipping SJ. Hemorrhagic cystitis as an unexpected adverse reaction to temozolomide: Case report. Am J Clin Oncol. 2002;25:513–4.
    1. Marx CM, Alpert SE. Ticarcillin- induced cystitis. Cross reactivity with related pencillin. Am J Dis Child. 1984;138:670–2.
    1. Bracis R, Sanders CV, Gilbert DN. Methicillin hemorrhagic cystitis. Antimicrob Agents Chemother. 1977;12:438–9.
    1. Andriole GL, Brickman C, Lack EE, Sesterhenn IA, Javadpour N, Linehann WM, et al. Danazol-induced cystitis: An undescibed source of hematuria in patient with hereditary angioneurotic edema. J Urol. 1986;135:44–6.
    1. Crawford ML, Waller PC, Wood SM. Severe cystitis associated with Tiaprofenic acid. Br J Urol Apr. 1997;79:578–84.
    1. Mayersak JS, Viviano CJ. Transurethral insertion of vaginal contraceptive suppository into the urinary bladder. Wis Med J. 1994;93:13–5.
    1. Nellans RE, Ellis LR, Kenny GM. Ether cystitis. JAMA. 1985;254:530.
    1. Bramble FJ, Morley R. Cystitis associated with allopurinol. Br J Urol. 1997;79:817.
    1. Goldfarb M, Finnelli R. Necrotizing cystitis. Secondary to “bootleg” methaqualone. Urology. 1974;3:54–5.
    1. Ross RR, Jr, Conway GF. Hemorrhagic cystiyis following overdose of methenamine mandealate. Am J Dis Child. 1970;119:86–7.
    1. Kim SJ, Koh DH, Park JS, Ahn HS, Choi JB, Kim YS. Hemorrhagic cystitis due to intravesical instillation of gentian violet recovered with conservative therapy. Yonsei Med J. 2003;44:163–5.
    1. Osorio AV, Simckes AM, Hellerstein S. Hemorrhagic cystitis caused by acetic acid instillation. J Urol. 1996;155:685.
    1. Folland DS, Kimbourgh RD, Cline RE, Swiggart RC, Schaffner W. Acute hemorrhagic cystitis. Industrial exposure to the pesticide chlordimeform. JAMA. 1991;116:1052–5.
    1. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys. 1995;31:1341–6.
    1. Chong KT, Hampson NB, Corman JM. Early hyperbaric therapy improves outcome for radiation- induced hemorrhagic cystitis. Urology. 2005;65:649–53.
    1. Corman JM, McClure D, Pritchett R, Kozlowski P, Hampson NB. Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen. J Urol. 2003;169:2200–2.
    1. Oration JP. Complications following radiation therapy in carcinoma cervix and their treatment. Am J Obstet Gynecol. 1964;88:854–66.
    1. Pasquier D, Hoelscher T, Schmutz J, Dische S, Mathieu D, Baumann M, et al. Hyperbaric oxygen therapy in the treatment of radio-induced lesions in normal tissue: A literature review. Radiother Oncol. 2004;72:1–13.
    1. Denton AS, Clarke NW, Maher EJ. Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis. Cochrane Database Syst Rev. 2002;3:CD001773.
    1. Gray LH, Conger AD, Ebert M, Hornesy S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol. 1953;26:638–48.
    1. Marx RE, Ehler WJ, Tayapongsak P, Pierce LW. Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg. 1990;160:519–24.
    1. Bevers RF, Bakker DJ, Kurth KH. Hyperbaric oxygen treatment for haemorrhagic cystitis. Lancet. 1995;346:803–5.
    1. Chong KT, Hampson NB, Corman JM. Early hyperbaric oxygen theraphy improves outcome for radiation induced haemorrhagic cystitis. Urology. 2005;65:649–53.
    1. Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen in prevention and treatment of delayed radiation injuries: An evidence based approach. Undersea Hyperb Med. 2002;29:4–30.
    1. Norkool DM, Hampson NB, Gibbons RP, Weismann RM. Hyperbaric oxygen therapy for radiation -induced haemorrhagic cystitis. J Urol. 1993;150:332–4.
    1. Preventing radiation-induced cystitis with Hyaluronic acid. J Support Oncol. 2003;1:215.
    1. Veerasarn V, Khorprasert C, Lorvidhaya V, Sangruchi S, Tantivatana T, Narkwong L, et al. Reduced recurrence of late haemorrhagic cystitis by WF10 therapy in cervical cancer patients: A multicenter, randomized, two-arm, open-label trial. Radiother Oncol. 2004;73:179–85.
    1. Veerasarn V, Boonnuch W, Kakanaporn C. A phase II study to evaluate WF 10 in patients with late haemorrhagic radiation cystitis and proctitis. Gynecol Oncol. 2006;100:179–84.
    1. Erard V, Storer B, Corey L, Nolkamper J, Huang ML, Limaye A, Boeckh M. BK virus infection in haematopoietic stem cell transplant receipents: Frequency, risk factors and association with post engraftment haemorrhagic cystitis. Clin Infect Dis. 2004;39:1861–5.
    1. Hofland CA, Eron LJ, Washecka RM. Haemorrhagic adenovirus cystitis after renal transplantation. Transplant Proc. 2004;36:3025–7.
    1. Paduch DA. Viral lower urinary tract infections. Curr Urol Rep. 2007;8:324–35.
    1. Dropulic LK, Jones RJ. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplantation. 2008;41:11–8.
    1. Johnson WD, Jr, Johnson CW, Lowe FC. Tuberculosis and parasitic diseases of the genitourinary system. In: Walsh PC, Retik AB, Vaughan Jr DE, editors. Campbell’s Urology. 8th ed. Philadelphia: WB Saunders Co; 2002. pp. 743–96.
    1. Malek RS, Wahner-Roedler DL, Gertz MA, Kyle RA. Primary localized amyloidosis of the bladder: Experience with dimethyl sulfoxide therapy. J Urol. 2004;168:1018–20.
    1. Kok LP. Boon’s disease: Haemorrhagic cystitis in conjuction with massive exfoliation of degenerated urothelial cells (apoptosis?) during intercontinental flights in an otherwise healthy person. Diagn Cytopathol. 2001;25:361–4.
    1. Droller MJ, Saral R, Santos G. Prevention of cyclophosphamide- induced hemorrhagic cystitis. Urology. 1982;20:256–8.
    1. Heath JA, Mishra S, Mitchell S, Waters KD, Tiedemann K. Estrogen as treatment of haemorrhagic cystitis in children and adolescents undergoing bone marrow transplantation. Bone Marrow Transplant. 2006;37:523–6.
    1. Hampson S, Woodhouse C. Sodium pentosanpolysulphate in the management of haemorrhagic cystitis: Experience with 14 patients. Eur Urol. 1994;25:40–2.
    1. Focosi D, Maggi F, Pistolesi D, Benedetti E, Papineschi F, Galimberti S, et al. Hyperbaric oxygen therapy in BKV-associated hemorrhagic cystitis refractory to intravenous and intravesical cidofovir: Case report and review of literature. Leuk Res. 2009;33:556–60.
    1. Singh I, Laungani GB. Intravesical epsilon aminocaproic acid in management of intractable bladder hemorrhage. Urology. 1992;40:227–9.
    1. Arrizabalaga M, Extramiana J, Parra JL, Ramos C, Diaz Gonzalez R, Leiva O. Treatment of massive hematuria with aluminum salts. Br J Urol. 1987;60:223–6.
    1. Choong SK, Walkden M, Kirby R. The management of intractable hematuria. BJU. 2000;86:951–9.
    1. Perazella M, Brown E. Acute aluminum toxicity and alum bladder irrigation in patients with renal failure. Am J Kidney Dis. 1993;21:44–6.
    1. Bogris SL, Johal NS, Hussein I, Duffy PG, Mushtaq I. Is it safe to use aluminum in the treatment of pediatric hemorrhagic cystitis? A case discussion of aluminum intoxication and review of the literature. J Pediatr Hematol Oncol. 2009;31:285–8.
    1. Ragavaiah NV, Soloway MS. Anuria following silver nitrate irrigations for intractable bladder haemorrhage. J Urol. 1977;118:681–2.
    1. Levine LA, Krane DM. Evaluation of carboprost tromethamine in the treatment of cyclophosphamide- induced haemorrhagic cystitis. Cancer. 1990;66:242–5.
    1. Laszlo D, Bosi A, Guidi S, Saccardi R, Vannucchi AM, Lombardini L, et al. Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogeneic bone marrow transplantation. Haematologica. 1995;80:421–5.
    1. Jeremy JY, Mikhailidis DP, Dandona P. The rat urinary bladder produces prostacyclin as well as other prostaglandins. Prostaglandins Leukot Med. 1984;16:235–48.
    1. Kranc DM, Kim J, Straus F, Levine LA. Prophylactic and therapeutic carbo prost tromethamine bladder irrigation in rats with cyclophosphamide- induced haemorrhagic cystitis. J Urol. 1992;148:1326–30.
    1. Bridges B, Donegan S, Badros A. Cidofovir bladder instillation for the treatment of BK haemorrhagic cystitis after allogeneic stem cell transplantation. Am J Hematol. 2006;81:535–7.
    1. Miodosky M, Abdul-Hai A, Tsirigotis P, Or R, Bitan M, Resnick IB, et al. Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate. Bone Marrow Transplant. 2006;38:507–11.
    1. Iavazzo C, Athanasiou S, Pitsouni E, Falagas ME. Hyaluronic acid: An effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis? Eur Urol. 2007;51:1534–40.
    1. De Vries CR, Freiha FS. Hemorrhagic cystitis: A review. J Urol. 1990;143:1–9.
    1. Vicente J, Rios G, Caffaratti J. Intravesical formalin for the treatment of massive hemorrhagic cystitis: Retrospective review of 25 cases. Eur Urol. 1990;18:204–6.
    1. Ouwenga MK, Langston MD, Campbell SC. Use of fibrin sealant in recalcitrant hemorrhagic cystitis. J Urol. 2004;172:1348.
    1. McIvor J, Williams G, Southcott RD. Control of severe haemorrhage by therapeutic embolisation. Clin Radiol. 1982;33:561–7.
    1. Gonzalez CM, Case JR, Nadler RB. Glutaraldehyde cross-linked collagen occlusion of the ureteral orifices with percutaneous nephrostomy: A minimally invasive option of refractory hemorrhagic cystitis. J Urol. 2001;166:977–8.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe